Amaury Ojeanson
Forskare vid Institutionen för farmaci; Farmakokinetik och Farmakodynamik
- E-post:
- amaury.ojeanson@uu.se
- Besöksadress:
- Biomedicinskt Centrum BMC, Husargatan 3
- Postadress:
- Box 580
751 23 UPPSALA

Publikationer
Senaste publikationer
-
Ingår i Journal of Antimicrobial Chemotherapy, s. 79-86, 2025
- DOI för Therapeutic drug monitoring (TDM) of β-lactam/β-lactamase inhibitor (BL/BLI) drug combinations: insights from a pharmacometric simulation study
- Ladda ner fulltext (pdf) av Therapeutic drug monitoring (TDM) of β-lactam/β-lactamase inhibitor (BL/BLI) drug combinations: insights from a pharmacometric simulation study
-
Ingår i CPT, s. 1650-1660, 2025
- DOI för Machine Learning-Based Model Selection and Averaging Outperform Single-Model Approaches for a Priori Vancomycin Precision Dosing
- Ladda ner fulltext (pdf) av Machine Learning-Based Model Selection and Averaging Outperform Single-Model Approaches for a Priori Vancomycin Precision Dosing
-
Ingår i JAC - Antimicrobial Resistance, 2025
- DOI för Evaluation of ceftazidime/avibactam in combination with colistin against KPC-2-producing Klebsiella pneumoniae in static and dynamic time-kill experiments
- Ladda ner fulltext (pdf) av Evaluation of ceftazidime/avibactam in combination with colistin against KPC-2-producing Klebsiella pneumoniae in static and dynamic time-kill experiments
-
Ingår i CPT, s. 1077-1086, 2025
- DOI för Middle-Out Physiologically Based Pharmacokinetic Modeling to Support Pediatric Dosing Recommendation for Alectinib
- Ladda ner fulltext (pdf) av Middle-Out Physiologically Based Pharmacokinetic Modeling to Support Pediatric Dosing Recommendation for Alectinib
-
2025
Alla publikationer
Artiklar i tidskrift
-
Ingår i Journal of Antimicrobial Chemotherapy, s. 79-86, 2025
- DOI för Therapeutic drug monitoring (TDM) of β-lactam/β-lactamase inhibitor (BL/BLI) drug combinations: insights from a pharmacometric simulation study
- Ladda ner fulltext (pdf) av Therapeutic drug monitoring (TDM) of β-lactam/β-lactamase inhibitor (BL/BLI) drug combinations: insights from a pharmacometric simulation study
-
Ingår i CPT, s. 1650-1660, 2025
- DOI för Machine Learning-Based Model Selection and Averaging Outperform Single-Model Approaches for a Priori Vancomycin Precision Dosing
- Ladda ner fulltext (pdf) av Machine Learning-Based Model Selection and Averaging Outperform Single-Model Approaches for a Priori Vancomycin Precision Dosing
-
Ingår i JAC - Antimicrobial Resistance, 2025
- DOI för Evaluation of ceftazidime/avibactam in combination with colistin against KPC-2-producing Klebsiella pneumoniae in static and dynamic time-kill experiments
- Ladda ner fulltext (pdf) av Evaluation of ceftazidime/avibactam in combination with colistin against KPC-2-producing Klebsiella pneumoniae in static and dynamic time-kill experiments
-
Ingår i CPT, s. 1077-1086, 2025
- DOI för Middle-Out Physiologically Based Pharmacokinetic Modeling to Support Pediatric Dosing Recommendation for Alectinib
- Ladda ner fulltext (pdf) av Middle-Out Physiologically Based Pharmacokinetic Modeling to Support Pediatric Dosing Recommendation for Alectinib
-
Ingår i JAC - Antimicrobial Resistance, 2025
- DOI för A model-based evaluation of the pharmacokinetics-pharmacodynamics (PKPD) of avibactam in combination with ceftazidime
- Ladda ner fulltext (pdf) av A model-based evaluation of the pharmacokinetics-pharmacodynamics (PKPD) of avibactam in combination with ceftazidime
-
Ingår i International Journal of Antimicrobial Agents, 2025
- DOI för Ceftazidime-avibactam (CAZ-AVI) pharmacokinetics in critically ill patients undergoing continuous venovenous hemodiafiltration (CVVHDF)
- Ladda ner fulltext (pdf) av Ceftazidime-avibactam (CAZ-AVI) pharmacokinetics in critically ill patients undergoing continuous venovenous hemodiafiltration (CVVHDF)
-
Ingår i CPT, s. 396-409, 2024
- DOI för Evaluation of the potential impact on pharmacokinetics of various cytochrome P450 substrates of increasing IL-6 levels following administration of the T-cell bispecific engager glofitamab
- Ladda ner fulltext (pdf) av Evaluation of the potential impact on pharmacokinetics of various cytochrome P450 substrates of increasing IL-6 levels following administration of the T-cell bispecific engager glofitamab